We are about to cure MS in the next 10 years,even though we do not know its cause: No

Abstract

Get full access to this article

View all access options for this article.

References

International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.

Burt

Loh

Cohen

. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing–remitting multiple sclerosis: a phase I/II study. Lancet Neurol 2009; 8: 244–253.

Sawcer

Ban

Wason

Dudbridge

. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3–10.

Huang

Jarjour

Nait Oumesmar

. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011; 14: 45–53.

Confavreux

Vukusic

Adeleine

. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770–782.

Vergo

Craner

Etzensperger

. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain 2011; 134: 571–584.

Snowden

Passweg

Moore

. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol 2004; 31: 482–488.